FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Jubilant Draximage Draximage MAA Recall

Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2

Jubilant Draximage Inc

Risk level
Class II
Reported by FDA
Jul 20, 2022
Recall ID
D-1189-2022
Check your lot numberHow we source this data

Summary

Jubilant Draximage recalled Draximage MAA starting Jun 16, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1189-2022 on Jul 20, 2022. Reason: Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

Product description

Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2.5 mg per vial, 30 glass vials per carton, Rx Only, Manufactured for Jubilant Draximage Inc. Kirkland, Canada, NDC 65174-270-30.

Lot numbers, UPCs & expiration codes

Lot # 1H005, exp. date Nov 30, 2023

Where it was sold

Product was distributed to retailers nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1189-2022
Classification
Class II
Status
Terminated
Recall initiated
Jun 16, 2022
FDA report date
Jul 20, 2022
Quantity
519 cartons/30 vials each
Recall type
Voluntary: Firm initiated
Recalling firm
Jubilant Draximage Inc

Original FDA data

Every field from FDA enforcement report D-1189-2022, exactly as published.

Show all FDA fields
City
Kirkland
Status
Terminated
Country
Canada
Event ID
90455
Address
16751 Rte Transcanadienne
Code information
Lot # 1H005, exp. date Nov 30, 2023
Report date
Jul 20, 2022
Product type
Drugs
Recall number
D-1189-2022
Classification
Class II
Recalling firm
Jubilant Draximage Inc
Product quantity
519 cartons/30 vials each
Termination date
Jul 25, 2023
Reason for recall
Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2.5 mg per vial, 30 glass vials per carton, Rx Only, Manufactured for Jubilant Draximage Inc. Kirkland, Canada, NDC 65174-270-30.
Distribution pattern
Product was distributed to retailers nationwide.
Recall initiation date
Jun 16, 2022
Initial firm notification
Letter
Center classification date
Jul 8, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1189-2022, published Jul 20, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls